Anatomical Shoulder™ Fracture PMCF Study
1 other identifier
interventional
52
3 countries
3
Brief Summary
The purpose of this study is to obtain outcomes data on the Anatomical Shoulder Fracture System by analysis of standard scoring systems and radiographs. Outcome data will be collected using the following standard scoring systems: \- Constant and Murley Score
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2007
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 5, 2007
CompletedFirst Submitted
Initial submission to the registry
June 4, 2015
CompletedFirst Posted
Study publicly available on registry
June 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 29, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 11, 2024
CompletedResults Posted
Study results publicly available
June 12, 2025
CompletedJune 12, 2025
February 1, 2025
9.7 years
June 4, 2015
February 24, 2025
May 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional Performance
Constant \& Murley Score. This evaluates clinical parameters such as range of motion, power, level of pain and functional ability. The score ranges from 0 - 100 with a higher score representing a better outcome.
5 years
Study Arms (1)
Fracture device
OTHERPatient were treated with an Anatomical Shoulder Fracture device.
Interventions
Implantation of the Anatomical Shoulder Fracture System
Eligibility Criteria
You may qualify if:
- Age - 18 years minimum.
- Sex - male and female.
- General Health - the patient should be able to undergo surgery and participate in a follow-up program based upon physical examination and medical history.
- Informed Consent - patient or patient's legal representative has signed a 'Patient Informed Consent form'.
- Indications - Diagnosis of trauma in the affected joint with the indication for shoulder hemiarthroplasty.
You may not qualify if:
- Patient is skeletally immature.
- Patient is pregnant.
- Patient is unwilling or unable to cooperate in a follow-up program.
- Patient is planned for a bilateral shoulder replacement.
- Patient shows one or more of the following medical conditions:
- Pathological Fracture
- Active Infection
- Patient requires one or more of the following medical interventions:
- Revision surgery (non-union)
- Inverse fracture prosthesis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zimmer Biometlead
Study Sites (3)
Klinikum Augsburg
Augsburg, 86156, Germany
Uniklinik Balgrist
Zurich, 8008, Switzerland
The Pennine Acute Hospital NHS Trust
Manchester, M8 5RB, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Elliott Goff
- Organization
- Zimmer Biomet
Study Officials
- STUDY CHAIR
Elliott Goff, PhD
Zimmer Biomet, Jr. Clinical Project Lead
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- GT60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 4, 2015
First Posted
June 8, 2015
Study Start
July 5, 2007
Primary Completion
March 29, 2017
Study Completion
March 11, 2024
Last Updated
June 12, 2025
Results First Posted
June 12, 2025
Record last verified: 2025-02